Integra LifeSciences Holdings (IART)

Financial leverage ratio

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Total assets US$ in thousands 4,037,420 4,065,800 4,074,500 4,078,220 3,781,990 3,739,370 3,777,600 3,742,400 3,889,760 3,807,010 3,752,860 3,672,000 3,782,380 3,774,460 3,712,790 3,741,550 3,615,140 3,453,520 3,391,760 3,447,560
Total stockholders’ equity US$ in thousands 1,545,280 1,521,590 1,534,200 1,597,950 1,587,880 1,579,220 1,683,160 1,674,940 1,804,400 1,724,410 1,660,920 1,615,200 1,684,800 1,631,690 1,574,980 1,529,330 1,514,870 1,397,990 1,349,100 1,341,800
Financial leverage ratio 2.61 2.67 2.66 2.55 2.38 2.37 2.24 2.23 2.16 2.21 2.26 2.27 2.25 2.31 2.36 2.45 2.39 2.47 2.51 2.57

December 31, 2024 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $4,037,420K ÷ $1,545,280K
= 2.61

Integra LifeSciences Holdings has shown a gradual decrease in its financial leverage ratio over the past few years. The ratio decreased from 2.57 as of March 31, 2020, to 2.61 as of December 31, 2024. This trend indicates that the company has been reducing its reliance on debt to finance its operations and investments. However, it is worth noting that there were fluctuations in the ratio during this period, with some slight increases and decreases along the way. Overall, the downward trend suggests a positive shift towards a lower level of financial risk and increased financial stability for the company.